Search results
Found 9 matches for
Identifying fake COVID-19 vaccines by analysing vial labels and vaccine liquids
31 January 2025
Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine v…
Optimising testing for disease surveillance with machine learning
19 December 2024
A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
New AI-led science initiative will help protect communities hit by climate change in East Africa
4 July 2024
The United Nations World Food Programme (WFP), Oxford University Physics Department, IGAD Climate Prediction and Applications Centre (ICPAC), and various national forecasting and meteorology agencies across east Africa are joining forces to pioneer a transformative initiative that is revolutionising extr…
Communication, Narratives and Antimicrobial Resistance
6 June 2024
The World Health Organisation has declared Antimicrobial Resistance (AMR) as one of the ‘top global and public health development threats.’ The Communication, Narratives and Antimicrobial Resistance conference took place on the 16th of May at Merton College, Oxford, as part of the TORCH Medica…
New small molecule found to suppress the evolution of antibiotic resistance in bacteria
28 May 2024
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and the Department of Pharmacology at Oxford University, have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.
Forecasting how best to control and eliminate Neglected Tropical Diseases
26 April 2024
Neglected tropical diseases (NTDs) are a major cause of death, disability, and economic hardship worldwide, particularly in low- and middle-income countries. While many of these diseases are targeted for control, elimination, or eradication by 2030, achieving those targets will be challenging due to disruptions to…
£4.3m boost for Oxford-Glasgow spinout tackling antimicrobial resistance
15 November 2023
Glox Therapeutics, a company pioneering the development of precision antibiotics to combat antimicrobial resistance, has raised £4.3M in early-stage funding to develop effective targeted therapeutics against antibiotic-resistant gram-negative bacteria.
New AI tool could help predict viral outbreaks
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new…
Researchers develop new breath-driven concept set to transform access to hand prosthetics
28 July 2022
The new air-powered hand provides a lightweight, low-maintenance and easy-to-use body-powered prosthetic option particularly well suited for children and those in low and middle-income countries.